SCITOVATION, LLC

DURHAM, NC · Founded 2015 · Biotech · Private

DRIIVE: a web-based platform combining in vitro reproductive toxicity assays with physiologically-based pharmacokinetic (PBPK) models to predict human-equivalent developmental toxicity doses

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · scitovation.com

Sector: Biotech
Headquarters: DURHAM, NC
Founded: 2015
Latest Form D: $50K, Oct 2020
Total capital: $4.3M

Federal grants: $4.2M; 6 awards · 2017–2026; Rank in peer group#14 of 36
Private capital raised: $90K; 2 Form D · last Oct 2020; 73 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

Latest events

May 2026Federal grantHealth and Human S · Phase II · Triage of Developmental and Reproductive Toxicants using an In vitro to In Vivo Extrapolation (IVIVE)-Toxicokinetic Computational modeling Application$983K
May 2025Federal grantHealth and Human S · Phase II · Triage of Developmental and Reproductive Toxicants using an In vitro to In Vivo Extrapolation (IVIVE)-Toxicokinetic Computational modeling Application$973K
Apr 2024Federal grantHealth and Human S · Phase II · Mutational profiling in human cells as an in vitro alternative to in vivo mutagenicity assessments$910K
Jul 2023Federal grantHealth and Human S · Phase I · Triage of Developmental and Reproductive Toxicants using an In vitro to In Vivo Extrapolation (IVIVE)-Toxicokinetic Computational modeling Application$270K
May 2023Federal grantHealth and Human S · Phase II · Mutational profiling in human cells as an in vitro alternative to in vivo mutagenicity assessments$910K
Oct 2020Private capital raisedForm D · SEC · 2nd filing$50K
Feb 2020Private capital raisedForm D · SEC · 1st filing$40K

Show 1 earlier federal award

May 2017Federal grantHealth and Human S · Phase I · Development of high sensitivity in vitro assay to detect DNA double strand breaks$147K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

33months

from SCITOVATION, LLC’s first federal award to its first private round.

First federal award · May 2017: Health and Human S · $147K
First Form D · Feb 2020: $40K · 1st Form D
Awards before first raise: 1 award

An association in public records, not a cause or a prediction.

Standing among 36 peers

Line = median

Biotech · Platform

Federal grants#14 · top 39%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings

Jean OrelienExecutive Officer, Director, PromoterNamed in SEC Form D filings
Ray GrossExecutive OfficerNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

Paulex Bio Inc.Similar federal contract value in Biotech · null in contracts
CYTOTERRA INC.Similar federal contract value in Biotech · null in contracts
Verismo Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
GELBCHEM, LLCSimilar federal contract value in Biotech · null in contracts
I-CORDIS, LLCSimilar federal contract value in Biotech · null in contracts
Path Biotech, LLCSimilar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.